Clinical Trials Directory

Trials / Completed

CompletedNCT03582072

CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

Contacting GPs to Reduce Unnecessary Prescriptions of Antibiotics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,796 (actual)
Sponsor
Public Health England · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This trial aims to reduce unnecessary prescription of antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically, GPs in practices whose prescribing has increase by more than 4% over the past year will receive a letter stating that "The great majority (80%) of practices in England reduced or stabilised their antibiotic prescribing rates in 2016/17. However, your practice is in the minority that have increased their prescribing by more than 4%." The letter will also contain a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.

Detailed description

The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group; the statistical analysis will compare prescribing in March, April, and over the summer (treating May-September as a single data point).

Conditions

Interventions

TypeNameDescription
BEHAVIORALletter from the CMOinformed GPs that: The great majority (80%) of practices in England reduced or stabilised their antibiotic prescribing rates in 2016/17. However, your practice is in the minority that have increased their prescribing by more than 4%.\*

Timeline

Start date
2018-02-27
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2018-07-10
Last updated
2020-03-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03582072. Inclusion in this directory is not an endorsement.